Gilead Sciences, Inc. (GILD) is in Healthcare, Drug Manufacturers - General, based in United States, listed on NasdaqGS. Market cap 182.40B USD. 52-week range 114.02 to 157.29 USD. Trailing P/E 18.4. Data as of 2026-10-09.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy ...